Our recent research
We’re funding the most exciting research projects that’ll make the biggest impact in the long term. This is what we’ve recently been doing to help drive progress for people living with a lung condition.
2018-19: £1.8 million for 16 new research grants
The focus of awards were projects tackling our priority disease areas:
- COPD: 2 grants totalling £41,600
- interstitial lung disease: 3 grants totalling over £143,000
- COPD and interstitial lung disease: 1 grant of £25,000
- mesothelioma: 9 grants totalling £1.5 million
We also funded a further award of £24,000 to investigate respiratory infections.
2017-2018: Our largest ever investment in research
This year, our awards totalled £2.7m for 20 promising research grants - our largest ever investment.
These studies focus on our priority diseases:
- chronic obstructive pulmonary disease (COPD)
- pulmonary fibrosis
- children’s lung diseases
We also launched the first Mesothelioma Research Network thanks to a generous award from the Victor Dahdaleh Foundation. The £5 million donation in 2016, over 5 years, means we can support invaluable research projects on mesothelioma
2016-17: Over £2.2m for 19 grants
This year, our awards totalled £2.2 million for 19 research grants:
- mesothelioma: 9 grants totalling £1.5 million were awarded
- COPD: one grant of £17,000 was awarded
- pulmonary fibrosis: 3 grants totalling £177,000 were awarded
- lung cancer: 3 grants of £312,000 were awarded
There were further awards totalling £172,000. 2 looked at respiratory infections, and individual awards looked at the impact of e-cigarettes and developing new breath-based analysis systems to help diagnose and treat lung disease.